| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human C1orf35/MMTAG2 recombinant protein (Position: R27-E154) was used as the immunogen for the MMTAG2 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
MMTAG2 Antibody / Mammary tumor antigen 2 is an antibody targeting MMTAG2. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, FACS, ELISA.
Key elements and design rationale
- Target: MMTAG2.
- Immunogen: E.coli-derived human C1orf35/MMTAG2 recombinant protein (Position: R27-E154) was used as the immunogen for the MMTAG2 a….
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
MMTAG2 antibody detects Mammary tumor antigen 2, encoded by the MMTAG2 gene. Mammary tumor antigen 2 is a protein identified in the context of murine mammary tumors and is associated with tumorigenesis, immune recognition, and viral oncogenesis.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
